Tremlett, Helen

Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity

Browne, P., Chandraratna, D., Angood, C., Tremlett, H., Baker, C., Taylor, B. V., & Thompson, A. J. (2014) · Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 1,223

Multiple sclerosis progression: time for a new mechanism-driven framework

Kuhlmann, T., Moccia, M., Coetzee, T., Cohen, J. A., Correale, J., Graves, J., Marrie, R. A., Montalban, X., Yong, V. W., Thompson, A. J., et al. (2023) · The Lancet Neurology

Multiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis

Cited by 667

Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria

Montalban, X., Lebrun-Frénay, C., Oh, J., Arrambide, G., Moccia, M., Pia Amato, M., Amezcua, L., Banwell, B., Bar-Or, A., Barkhof, F., et al. (2025) · The Lancet Neurology

Multiple Sclerosis Research StudiesPolyomavirus and related diseases

Cited by 551

The gut microbiome in human neurological disease: A review

Tremlett, H., Bauer, K. C., Appel‐Cresswell, S., Finlay, B. B., & Waubant, E. (2017) · Annals of Neurology

Gut microbiota and healthMultiple Sclerosis Research Studies

Cited by 535

Age Related Multiple Sclerosis Severity Score: Disability ranked by age

Manouchehrinia, A., Westerlind, H., Kingwell, E., Zhu, F., Carruthers, R., Ramanujam, R., Ban, M., Glaser, A., Sawcer, S., Tremlett, H., et al. (2017) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesHealth Systems, Economic Evaluations, Quality of Life

Cited by 174

Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance

for the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis, Marrie, R. A., Fisk, J. D., Yu, B. N., Leung, S., Elliott, L., Caetano, P., Warren, S., Evans, C., Wolfson, C., et al. (2013) · BMC Neurology

Multiple Sclerosis Research StudiesMedical Coding and Health Information

Cited by 163

Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts

Kingwell, E., Leung, A. L., Roger, E., Duquette, P., Rieckmann, P., & Tremlett, H. (2010) · Journal of the Neurological Sciences

Multiple Sclerosis Research StudiesClinical Reasoning and Diagnostic Skills

Cited by 60

Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme

Palace, J., Duddy, M., Lawton, M., Bregenzer, T., Zhu, F., Boggild, M., Piske, B., Robertson, N. P., Oger, J., Tremlett, H., et al. (2019) · Journal of Neurology, Neurosurgery & Psychiatry

Multiple Sclerosis Research StudiesHealth Systems, Economic Evaluations, Quality of Life

Cited by 44

Modelling disease progression in relapsing–remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort

Tilling, K., Lawton, M., Robertson, N., Tremlett, H., Zhu, F., Harding, K., Oger, J., & Ben-Shlomo, Y. (2016) · Health Technology Assessment

Multiple Sclerosis Research StudiesHealth Systems, Economic Evaluations, Quality of Life

Cited by 43

Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis: A Multiregional Population-Based Study

Ng, H. S., Zhu, F., Zhao, Y., Yao, S., Lu, X., Ekuma, O., Evans, C., Fisk, J. D., Marrie, R. A., & Tremlett, H. (2024) · Neurology

Multiple Sclerosis Research StudiesPharmacovigilance and Adverse Drug Reactions

Cited by 31